Access TeleCare’s Post

Miia Kivipelto, Professor in Clinical Geriatrics at Karolinska Institute and University of Eastern Finland, discussed meaningful benefits, from clinical trials to decision-making in clinical practice, in a panel session at the European Academy of Neurology 2024. In this MEDtalk, you can hear Miia Kivipelto give her perspective. 🔗Stay updated on EAN; https://lnkd.in/dV62Xfaq #EAN24 #Neurology

During our recent webinar, Tudor Jovin, MD, Chairman and Chief of Neurology at Cooper University Healthcare, shared his thoughts on “finishing the job” by continuing to care for stroke patients after an interventional procedure is done. Our webinar series explains how Kandu Health supports stroke survivors as they return home from the hospital and the benefits for patients and providers alike. Check out more from Dr. Jovin in the recordings of our webinars at https://lnkd.in/gBwkdQG3

At Neurology Solutions, we prioritize the immediate and continuous care of stroke patients with our dedicated team of stroke neurologists and strokologists, licensed by the Saudi Commission for Health Specialties (SCFHS). Our services are designed to provide timely interventions that can significantly impact patient outcomes. Why we advise you to choose Neurology Solutions؟ - Immediate Response: Our team is available round the clock, ensuring rapid assessment and treatment initiation. - Comprehensive Assessment: We conduct thorough evaluations to tailor treatment plans based on individual patient needs. - Advanced Treatment Options: From acute interventions to long-term rehabilitation strategies, we offer a full spectrum of care. - Multidisciplinary Approach: Collaborating closely with other healthcare professionals ensures holistic patient management. - Patient-Centered Care: We prioritize patient and family education, empowering them in the recovery journey. Our commitment extends beyond treatment—we advocate for stroke awareness and prevention strategies to promote community health. For institutions seeking reliable stroke care partners, Neurology Solutions stands ready to collaborate and elevate neurological care standards. #NeurologySolutions #StrokeCare #SCFHS

Anyone who has experienced the dementia journey via a loved one (like me) or otherwise knows the devastation and will appreciate what we're solving for and why this matters. Status quo care typically ends at diagnosis leaving patients and their care partners to their own devices to figure out what to do. Through our Mayo Clinic partnership, we've pioneered the first clinically validated early intervention for patients with MCI and early dementia and their care partners. Coupled with our CMS GUIDE program we can now precision manage and support patients/care partners via #virtualcare throughout this complicated journey - solving access challenges and completely changing the disease process trajectory and patient/care partner experience while improving every measure of outcome. Thank you Nuvance Health for your vision and partnership to support the 100,000+ people in the communities you serve who can now count on your innovative leadership to bring them a unique and game-changing solution for this condition. Thank you Paul Wright, Alex Mosteanu, MD, FACP, Amy Kohn Scott Costley, MD, Amy A. Forni #neuroglee, #nuvancehealth #NeurogleeConnect #VirtualCare #Dementia #DigitalHealth #MildCognitiveImpairment #DementiaCare #CognitiveCare #Neurology #Healthequity #Patientcare #CaregiverSupport #CareAtHome #Alzheimers #valuebaseddementiacare #CMSGUIDE #valuebasedcare

World Continence Week 2024 brings a vital opportunity to raise awareness about bladder and bowel issues, chronic pelvic pain, and other debilitating conditions. These challenges significantly impact the lives of patients, their families and carers, including those dealing with neurological conditions such as MS, Parkinson's, dementia, stroke, and brain or spinal cord injuries. As part of our commitment to improving continence care, we are thrilled to invite healthcare professionals to our upcoming webinar, 'Intermittent catheterisation in neurological patients: When do we start this conversation and how best to manage this pathway from suggestion to treatment?' Scheduled for Thursday, 11th July at 12:00, this webinar will address the challenges in identifying early, providing timely educating and initiating intermittent self-catheterisation for neurological patients. There will be valuable insights and management ‘tips and tricks’ and the opportunity to participate in an interactive question and answer session. Sign up now: https://lnkd.in/gNtKJfce World Continence Week is a reminder of the importance of our collective efforts to improve continence care and support those affected and living with bladder dysfunction. Read the full article on our website: https://lnkd.in/gWM39KPu #WCW2024 #continencematters

Miia Kivipelto, Professor in Clinical Geriatrics at Karolinska Institute and University of Eastern Finland, discussed meaningful benefits, from clinical trials to decision-making in clinical practice, in a panel session at the European Academy of Neurology 2024. In this MEDtalk, you can hear Miia Kivipelto give her perspective. 🔗Stay updated on EAN; https://lnkd.in/dmWquMkt #EAN #Neurology

Researchers from Verily, Duke University, and Stanford University demonstrate the potential for use of Verily’s Study Watch to help identify patients at risk for heart failure (HF). The study, published in the Journal of Cardiac Failure, investigates the association of digital walking measures with HF progression. “The study proves that there is more to walking than the number of steps. It shows that participants with subclinical heart failure had lower walking cadence and pace when compared to healthy or at risk individuals,” said Francois Haddad, MD, Clinical Professor of Cardiovascular Medicine at Stanford Medicine. Learn more: https://bit.ly/3vJ7mkt #PrecisionHealth #HealthData #HeartFailure

Last week, The National Academies of Sciences, Engineering, and Medicine (NASEM) gathered research scientists, advocates, and other experts to discuss persistent Lyme disease, including better ways to diagnose and treat it. Rhisa Parera (IG: @negraconlyme), a 34-year-old Lyme patient and advocate who wrote, directed, and produced the short film “Your Labs Are Normal,” gave the keynote address, sharing her personal experiences with Lyme. Rhisa developed knee, hip, and spine pain when she was just 7 years old. As a young adult, she suffered from gastrointestinal issues and neurological problems that eventually led to depression and suicidal thoughts. It took almost 20 years for Rhisa to get her Lyme disease diagnosis, but that was just the beginning. Finding a Lyme doctor who could help and undergoing costly and intense treatment was a major challenge. And Rhisa faced additional hurdles to care as a Black woman who most doctors dismissed. Rhisa highlights the need for more education and better medical training for doctors in her address. Read more on LymeDisease.org: https://lnkd.in/eUDR28Ad #projectlyme #lyme #tickbornediseases #lymediseaseawareness #chronicillness #chronicpain #chroniclyme #neurological #brain #lymewarrior #health #mentalhealth #patientstory #advocacy

With 50% of cavernoma patients having epilepsy, we’re pleased to announce a new treatment called Laser Interstitial Thermal Therapy (LITT). 🙌👏 LITT is available at King’s College Hospital and The Walton Centre for patients with Cavernoma Related Epilepsy (CRE) that is resistant to medication. LITT works by inserting a fiber optic laser into the skull to heat and coagulate the epilepsy-causing brain tissue at 50–90°C (122-194°F). Clinicians navigate through the brain using an MRI scanner to avoid nearby structures that need to be protected. If you have intractable CRE and would like to be considered for this treatment, speak to your neurologist or neurosurgeon. If they think you might be eligible and after discussing the risks you feel comfortable to proceed, then your clinician can refer you. Self-referral is not possible. For more information about LITT use the following link: 👇 https://lnkd.in/eKmp9F93 #litt #laserinterstitialthermaltherapy #cavernomarelatedepilepsy #intractableepilepsy

📢Breaking news! Is the pathophysiology of #OropharyngealDysphagia the same in older, post-stroke, dementia or Parkinson's disease patients? Read our last article to find out! https://lnkd.in/d5qtpH8Q